Concepedia

Kevin Atchison

KA

Statistics

Publications

24

Citations

2.7K

H-Index

20

Active since

1994

Affiliations

Pfizer (United States)(Current)

Princeton University

University of Alberta

Scripps Research Institute

Taiho Pharmaceutical (Japan)

Kevin Atchison is an author at Pfizer (United States) specializing in enzyme inhibition, pharmacology, and drug discovery.

Publications per year

1994–2020

24

Publications

24

Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor

Antonia F. Stepan, Chakrapani Subramanyam, Ivan Efremov et al. · Journal of Medicinal Chemistry · 2012 · 446 citations · Full text

, , +17

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

Simon Dujardin, Caitlin Commins, Aurélien Lathuilière et al. · Nature Medicine · 2020 · 444 citations · Full text

, , +16

Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels

David Riddell, Hua Zhou, Kevin Atchison et al. · Journal of Neuroscience · 2008 · 347 citations · Full text

, , +16

Acute γ-Secretase Inhibition Improves Contextual Fear Conditioning in the Tg2576 Mouse Model of Alzheimer's Disease

Thomas A. Comery, Robert Martone, Suzan Aschmies et al. · Journal of Neuroscience · 2005 · 212 citations · Full text

, , +17

3D Timelapse Analysis of Muscle Satellite Cell Motility

Ashley L. Siegel, Kevin Atchison, Kevin E. Fisher et al. · Stem Cells · 2009 · 178 citations · Full text

, , +17

1–5 of 24